Two Sigma Advisers’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Buy |
+64,570
| New | +$176K | ﹤0.01% | 2145 |
|
|
2025
Q1 | – | Sell |
-209,000
| Closed | -$341K | – | 2557 |
|
|
2024
Q4 | $341K | Buy |
209,000
+182,100
| +677% | +$297K | ﹤0.01% | 1927 |
|
|
2024
Q3 | $112K | Buy |
26,900
+7,800
| +41% | +$32.4K | ﹤0.01% | 2155 |
|
|
2024
Q2 | $104K | Buy |
+19,100
| New | +$104K | ﹤0.01% | 2318 |
|
|
2024
Q1 | – | Sell |
-22,400
| Closed | -$91.4K | – | 2611 |
|
|
2023
Q4 | $91.4K | Sell |
22,400
-20,300
| -48% | -$82.8K | ﹤0.01% | 2332 |
|
|
2023
Q3 | $165K | Sell |
42,700
-17,800
| -29% | -$68.9K | ﹤0.01% | 2134 |
|
|
2023
Q2 | $361K | Buy |
60,500
+100
| +0.2% | +$596 | ﹤0.01% | 1924 |
|
|
2023
Q1 | $198K | Buy |
60,400
+18,000
| +42% | +$58.9K | ﹤0.01% | 2273 |
|
|
2022
Q4 | $167K | Sell |
42,400
-17,800
| -30% | -$70.3K | ﹤0.01% | 2219 |
|
|
2022
Q3 | $361K | Sell |
60,200
-24,000
| -29% | -$144K | ﹤0.01% | 1978 |
|
|
2022
Q2 | $541K | Sell |
84,200
-28,700
| -25% | -$184K | ﹤0.01% | 1884 |
|
|
2022
Q1 | $933K | Buy |
112,900
+92,000
| +440% | +$760K | ﹤0.01% | 1674 |
|
|
2021
Q4 | $324K | Buy |
+20,900
| New | +$324K | ﹤0.01% | 2120 |
|